CLRB•benzinga•
Cellectar Biosciences Enters Into Definitive Agreements To Raise $2.5M From Sale Of Shares Priced At-Market For Nasdaq Purposes
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 5, 2025 by benzinga